According to the U.S. Food and Drug Administration (FDA), recent scientific studies studies support that certain telethermographic systems, also known as thermal imaging systems, may be used to measure surface skin temperature. The FDA has issued new guidance on these systems and non-contact infrared thermometers and their uses during the COVID-19 pandemic.
Key topics covered in the guidance document, Thermal Imaging Systems (Infrared Thermographic Systems/Thermal Imaging Cameras), include:
- The accuracy and effectiveness of thermal imaging systems in measuring surface skin temperature and their availability during the public health emergency
- The benefits and limitations of thermal imaging systems
- Proper use of thermal imaging systems
- How to prepare the area where you will use a thermal imaging system, prepare the system itself and prepare the person being evaluated
- Key questions and answers regarding use of thermal imaging systems during COVID-19
Want to learn more on this topic? Here are a few additional resources to explore:
- Fundamentals of Thermal Temperature and Fever Screening Solutions: In this on-demand SIA webinar, researchers from IPVM offer a fast-paced educational session on thermal temperature screening solutions, sometimes called fever detection cameras. In this 30-minute session, you’ll learn the fundamentals of how these systems work,the factors that impact accuracy and actionable tips and best practices for deploying such solutions.
- Telethermography Devices – Current FDA Considerations: Susan Kohn Ross of Mitchell Silberberg & Knupp LLP, chair of SIA’s Global Commerce Working Group, explores the current focus on temperature taking in the return-to-work environment and key challenges and considerations for adapting thermography machines to take advantage of this unexpected business opportunity and this new use as medical devices.
- Resources for COVID-19 and Business Continuity: SIA’s new resource page contains helpful information and guidance for people and businesses related to COVID-19, including new research and programs, health and prevention resources, regulatory and policy resources, business operations and continuity guidance and preparedness solutions and recommendations from SIA member companies.